123 related articles for article (PubMed ID: 34243107)
1. Clinical assessment of tumor regression grade systems in gastroesophageal adenocarcinoma following neoadjuvant chemotherapy.
Lütken C; Sheikh K; Willemoe GL; Achiam MP; Hasselby JP
Pathol Res Pract; 2021 Aug; 224():153538. PubMed ID: 34243107
[TBL] [Abstract][Full Text] [Related]
2. Assessment of tumor regression of esophageal adenocarcinomas after neoadjuvant chemotherapy: comparison of 2 commonly used scoring approaches.
Karamitopoulou E; Thies S; Zlobec I; Ott K; Feith M; Slotta-Huspenina J; Lordick F; Becker K; Langer R
Am J Surg Pathol; 2014 Nov; 38(11):1551-6. PubMed ID: 25140894
[TBL] [Abstract][Full Text] [Related]
3. Comparison of five tumor regression grading systems for gastric adenocarcinoma after neoadjuvant chemotherapy: a retrospective study of 192 cases from National Cancer Center in China.
Zhu Y; Sun Y; Hu S; Jiang Y; Yue J; Xue X; Yang L; Xue L
BMC Gastroenterol; 2017 Mar; 17(1):41. PubMed ID: 28292272
[TBL] [Abstract][Full Text] [Related]
4. Tumor regression grading after neoadjuvant treatment of esophageal and gastroesophageal junction adenocarcinoma: results of an international Delphi consensus survey.
Saliba G; Detlefsen S; Carneiro F; Conner J; Dorer R; Fléjou JF; Hahn H; Kamaradova K; Mastracci L; Meijer SL; Sabo E; Sheahan K; Riddell R; Wang N; Yantiss RK; Lundell L; Low D; Vieth M; Klevebro F
Hum Pathol; 2021 Feb; 108():60-67. PubMed ID: 33221343
[TBL] [Abstract][Full Text] [Related]
5. Prospective evaluation of MR-TRG (Tumor Regression Grade) in esophageal cancer after neo-adjuvant therapy: Preliminary results.
Chapellier P; Fasquelle F; Saglietti C; Kinj R; Mantziari S; Schäfer M; Haefliger L; Jreige M; Vietti Violi N; Sempoux C; Dromain C
Eur J Radiol; 2024 Feb; 171():111263. PubMed ID: 38159523
[TBL] [Abstract][Full Text] [Related]
6. Evaluation and Comparison of Predictive Value of Tumor Regression Grades according to Mandard and Becker in Locally Advanced Gastric Adenocarcinoma.
Tong Y; Zhu Y; Zhao Y; Shan Z; Liu D; Zhang J
Cancer Res Treat; 2021 Jan; 53(1):112-122. PubMed ID: 32777876
[TBL] [Abstract][Full Text] [Related]
7. International study group on rectal cancer regression grading: interobserver variability with commonly used regression grading systems.
Chetty R; Gill P; Govender D; Bateman A; Chang HJ; Deshpande V; Driman D; Gomez M; Greywoode G; Jaynes E; Lee CS; Locketz M; Rowsell C; Rullier A; Serra S; Shepherd N; Szentgyorgyi E; Vajpeyi R; Wang LM; Bateman A
Hum Pathol; 2012 Nov; 43(11):1917-23. PubMed ID: 22575264
[TBL] [Abstract][Full Text] [Related]
8. Interobserver agreement of a gastric adenocarcinoma tumor regression grading system that incorporates assessment of lymph nodes.
Tsekrekos A; Vieth M; Ndegwa N; Bateman A; Flejou JF; Grabsch HI; Mastracci L; Meijer SL; Saragoni L; Sheahan K; Shetye J; Yantiss R; Lundell L; Detlefsen S
Hum Pathol; 2021 Oct; 116():94-101. PubMed ID: 34284051
[TBL] [Abstract][Full Text] [Related]
9. The prognostic value of tumour regression grade following neoadjuvant chemoradiation therapy for rectal cancer.
Abdul-Jalil KI; Sheehan KM; Kehoe J; Cummins R; O'Grady A; McNamara DA; Deasy J; Breathnach O; Grogan L; O'Neill BD; Faul C; Parker I; Kay EW; Hennessy BT; Gillen P
Colorectal Dis; 2014 Jan; 16(1):O16-25. PubMed ID: 24119076
[TBL] [Abstract][Full Text] [Related]
10. Tumor regression grades: potential outcome predictor of locally advanced rectal adenocarcinoma after preoperative radiotherapy.
Peng YF; Yu WD; Pan HD; Wang L; Li M; Yao YF; Zhao J; Gu J
World J Gastroenterol; 2015 Feb; 21(6):1851-6. PubMed ID: 25684951
[TBL] [Abstract][Full Text] [Related]
11. Pathological Tumor Regression Grade Classifications in Gastrointestinal Cancers: Role on Patients' Prognosis.
Fanelli GN; Loupakis F; Smyth E; Scarpa M; Lonardi S; Pucciarelli S; Munari G; Rugge M; Valeri N; Fassan M
Int J Surg Pathol; 2019 Dec; 27(8):816-835. PubMed ID: 31416371
[TBL] [Abstract][Full Text] [Related]
12. Tumor stage after neoadjuvant chemotherapy determines survival after surgery for adenocarcinoma of the esophagus and esophagogastric junction.
Davies AR; Gossage JA; Zylstra J; Mattsson F; Lagergren J; Maisey N; Smyth EC; Cunningham D; Allum WH; Mason RC
J Clin Oncol; 2014 Sep; 32(27):2983-90. PubMed ID: 25071104
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant chemoradiation for patients with advanced oesophageal cancer - which response grading system best impacts prognostic discrimination?
Puetz K; Bollschweiler E; Semrau R; Mönig SP; Hölscher AH; Drebber U
Histopathology; 2019 Apr; 74(5):731-743. PubMed ID: 30636069
[TBL] [Abstract][Full Text] [Related]
14. Role of dynamic perfusion magnetic resonance imaging in patients with local advanced rectal cancer.
Ippolito D; Drago SG; Pecorelli A; Maino C; Querques G; Mariani I; Franzesi CT; Sironi S
World J Gastroenterol; 2020 May; 26(20):2657-2668. PubMed ID: 32523318
[TBL] [Abstract][Full Text] [Related]
15. Prognostic classification of histopathologic response to neoadjuvant therapy in esophageal adenocarcinoma.
Hölscher AH; Drebber U; Schmidt H; Bollschweiler E
Ann Surg; 2014 Nov; 260(5):779-84; discussion 784-5. PubMed ID: 25379849
[TBL] [Abstract][Full Text] [Related]
16. Histological grading based on poorly differentiated clusters is predictive of tumour response and clinical outcome in rectal carcinoma treated with neoadjuvant chemoradiotherapy.
Reggiani Bonetti L; Lionti S; Domati F; Pagliani G; Mattioli E; Barresi V
Histopathology; 2017 Sep; 71(3):393-405. PubMed ID: 28425130
[TBL] [Abstract][Full Text] [Related]
17. Gene expression profiles of tumor regression grade in locally advanced rectal cancer after neoadjuvant chemoradiotherapy.
Saigusa S; Tanaka K; Toiyama Y; Matsushita K; Kawamura M; Okugawa Y; Hiro J; Inoue Y; Uchida K; Mohri Y; Kusunoki M
Oncol Rep; 2012 Sep; 28(3):855-61. PubMed ID: 22711167
[TBL] [Abstract][Full Text] [Related]
18. YKL-40/c-Met expression in rectal cancer biopsies predicts tumor regression following neoadjuvant chemoradiotherapy: a multi-institutional study.
Senetta R; Duregon E; Sonetto C; Spadi R; Mistrangelo M; Racca P; Chiusa L; Munoz FH; Ricardi U; Arezzo A; Cassenti A; Castellano I; Papotti M; Morino M; Risio M; Cassoni P
PLoS One; 2015; 10(4):e0123759. PubMed ID: 25875173
[TBL] [Abstract][Full Text] [Related]
19. Comparison of tumor regression grading systems for locally advanced gastric adenocarcinoma after neoadjuvant chemotherapy.
Liu ZN; Wang YK; Zhang L; Jia YN; Fei S; Ying XJ; Zhang Y; Li SX; Sun Y; Li ZY; Ji JF
World J Gastrointest Oncol; 2021 Dec; 13(12):2161-2179. PubMed ID: 35070049
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcomes in elderly rectal cancer patients treated with neoadjuvant chemoradiotherapy: impact of tumor regression grade : Tumor regression grade after neoadjuvant chemoradiotherapy in elderly rectal cancer patients.
Rosa C; Di Tommaso M; Caravatta L; Taraborrelli M; Gasparini L; Di Guglielmo FC; Delli Pizzi A; Cinalli S; Marchioni M; Di Nicola M; Lanci C; Ausili Cefaro G; Genovesi D
J Cancer Res Clin Oncol; 2021 Apr; 147(4):1179-1188. PubMed ID: 33026518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
